Absence of fibroblast growth factor 2 does not prevent tumor formation originating from the RPE

Alessandro Foletti1, Julien Ackermann, Andrea Schmidt

  • 1ISREC (Swiss Institute for Experimental Cancer Research), Chemin des Boveresses 155, CH-1066 Epalinges, Switzerland.

Oncogene
|March 16, 2002
PubMed

Insights

Fibroblast growth factor 2 (FGF2) is not essential for retinal pigment epithelium (RPE) tumor development or metastasis. FGF2-deficient mice show no impairment, indicating FGF2 is not critical for RPE tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Fibroblast growth factor 2 (FGF2) role in tumor development is under investigation.
  • Transgenic mouse models (Tyrp1-Tag) spontaneously develop retinal pigment epithelium (RPE) tumors with metastatic potential.

Purpose of the Study:

  • To determine if FGF2 is essential for RPE tumor formation and metastasis.
  • To investigate the impact of FGF2 deficiency on tumor growth kinetics and survival rates.

Main Methods:

  • Generation of FGF2-deficient (FGF2-/-) mice.
  • Crossbreeding FGF2-/- mice with Tyrp1-Tag transgenic mice to create RPE tumor models lacking FGF2.
  • Isolation and characterization of RPE tumor cell lines from both wild-type and FGF2-deficient mice.
  • Subcutaneous injection of tumor cells into nude mice to assess tumor formation and growth.

Main Results:

  • FGF2-deficient mice are healthy, with normal growth and development.
  • Tyrp1-Tag mice lacking FGF2 developed RPE tumors that metastasized to the spleen and lymph nodes.
  • Tumor growth and survival rates in FGF2-deficient Tyrp1-Tag mice were identical to those expressing FGF2.
  • RPE tumor cell lines derived from FGF2-deficient mice formed vascularized tumors in vivo, independent of FGF2 presence.

Conclusions:

  • FGF2 is not essential for the initiation or progression of RPE tumors.
  • Tumor growth and metastasis in this model are independent of FGF2.
  • These findings suggest that FGF2 may not be a critical factor for tumor growth in general.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...